[HTML][HTML] Biomarkers for hepatocellular carcinoma based on body fluids and feces

MC Guan, W Ouyang, MD Wang, L Liang… - World Journal of …, 2021 - ncbi.nlm.nih.gov
Novel non-/minimally-invasive and effective approaches are urgently needed to supplement
and improve current strategies for diagnosis and management of hepatocellular carcinoma …

[HTML][HTML] APEX1 is a novel diagnostic and prognostic biomarker for hepatocellular carcinoma

L Cao, H Cheng, Q Jiang, H Li, Z Wu - Aging (Albany NY), 2020 - ncbi.nlm.nih.gov
In this study, we analyzed the expression and clinical significance of apyrimidinic
endodeoxyribonuclease 1 (APEX1) in hepatocellular carcinoma (HCC). The APEX1 mRNA …

Association of postoperative biomarker response with recurrence and survival in patients with hepatocellular carcinoma and high alpha-fetoprotein expressions (> 400 …

L Liang, MD Wang, YM Zhang, WG Zhang… - Journal of …, 2021 - Taylor & Francis
Background High alpha-fetoprotein (AFP) expressions (> 400 ng/mL) are associated with
poor oncological characteristics for hepatocellular carcinoma (HCC). However, prognosis …

[HTML][HTML] Effect of surgical margin on postoperative prognosis in patients with solitary hepatocellular carcinoma: a propensity score matching analysis

Z Zhou, L Qi, Q Mo, Y Liu, X Zhou, Z Zhou… - Journal of …, 2021 - ncbi.nlm.nih.gov
Objective: The effect of surgical margin (SM) on the postoperative prognosis of patients with
solitary hepatocellular carcinoma (HCC) remains controversial. This study aimed to evaluate …

[HTML][HTML] Prognostic significance of postoperative serological incomplete conversion of AFP and PIVKA-II after hepatic resection for hepatocellular carcinoma: a …

M Wang, G Qian, H Xiao, X Liu, L Sun, Z Chen… - The …, 2024 - academic.oup.com
Background The value of serum biomarkers, particularly alpha-fetoprotein (AFP) and protein
induced by vitamin K absence or antagonist-II (PIVKA-II), gains increasing attention in …

[HTML][HTML] Association between early response of alpha-fetoprotein and treatment efficacy of systemic therapy for advanced hepatocellular carcinoma: A multicenter …

G Hou, B Liu, ZQ Fan, C Li, JP Zhang, YH Guo… - Frontiers in …, 2023 - frontiersin.org
Background Alpha-fetoprotein (AFP) is a well-identified biomarker in hepatocellular
carcinoma (HCC). However, only limited AFP-related studies have evaluated its early …

[PDF][PDF] A novel post-operative ALRI model accurately predicts clinical outcomes of resected hepatocellular carcinoma patients

M Liao, J Sun, Q Zhang, C Tang, Y Zhou, M Cao… - Frontiers in …, 2021 - frontiersin.org
Background Hepatocellular carcinoma (HCC) is one of the leading malignant tumors
worldwide. Prognosis and long-term survival of HCC remain unsatisfactory, even after …